gvtcx

Automated Molecular PCR Platform

NHS Blood and Transplant Published 18 Feb 2026 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£404,383
Statuscomplete
Category (CPV) 38000000
Deadline3 Nov 2025
Contract start1 Dec 2025
Contract end30 Nov 2028
Procedureselective
SME suitableNo
OCIDocds-b5fd17-91ed65f2-31ef-427c-9cef-e4e24473a4e8

Award

SupplierValueDateStatus
Elitech UK Limited £337,798 18 Feb 2026 active

description

In May 2023, universal, post-donation screening for HHV-8 antibodies was added to the portfolio of tests required for deceased organ donor characterisation in the UK. Routine pre-donation testing for other required infection markers continue to be performed on an urgent 24/7 basis by a network of UK wide NHS diagnostic laboratories.

MSL Virology require a fully automated platform to perform testing for HHV8 DNA in plasma and whole blood samples. MSL Virology also requires a fully automated platform to perform testing for CMV DNA, HEV RNA and HBV DNA in EDTA plasma samples.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
18 Feb 2026 Award (award) · d82f7774-1df2-40d9-8772-a6b8103d43d2-884564

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.